Restraint stress induces connexin-43 translocation via α-adrenoceptors in rat heart

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2693-2701

  Unuma, Kana ^a,b   Shintani Ishida, Kaori ^a   Yahagi, Naoki ^c   Tsushima, Kensuke ^c   Shimosawa, Tatsuo ^c   Ueyama, Takashi ^d   Yoshida, Ken Ichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

adrenoceptor; blocker; Arrhythmia; Connexin 43; Emotional stress

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BUNAZOSIN; CONNEXIN 43; GAP JUNCTION PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOSORBIDE DINITRATE; METOPROLOL; PRAZOSIN; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE FLUCTUATION; CONTROLLED STUDY; DRUG EFFECT; FRACTIONATION; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; IMMOBILIZATION STRESS; INTERCALATION COMPLEX; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; SYMPATHETIC FUNCTION; WESTERN BLOTTING;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; CONNEXIN 43; GAP JUNCTIONS; ISOSORBIDE DINITRATE; MALE; METOPROLOL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITRIC OXIDE DONORS; PROPRANOLOL; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; RESTRAINT, PHYSICAL; STRESS, PHYSIOLOGICAL;

EID: 78649697851     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0529     Document Type: Article

References (44)

1. Uemura K, Ueyama T, Shintani-Ishida K, Unuma K, Yoshida K. An autopsy report on four sudden cardiac death cases by immobilization. Intern Med J 2008; 15: 301-305.
2. Stratton SJ, Rogers C, Brickett K, Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med 2001; 19: 187-191.
3. Lecomete D, Fornes P, Nicolas G. Stressful events as a trigger of sudden death: A study of 43 medico-legal autopsy cases. Forensic Sci Int 1996; 79: 1-10.
4. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000; 343: 1355-1361.
5. Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation 2002; 106: 1800-1805.
6. Selye H. The evolution of the stress concept: Stress and cardiovascular disease. Am J Cardiol 1970; 26: 289-299.
7. van Veen AA, van Rijen HV, Opthof T. Cardiac gap junction channels: Mmodulation of expression and channel properties. Cardiovasc Res 2001; 5: 217-229.
8. Jongsma HJ, Rook MB. Morphology and electrophysiology of cardiac gap junction channels. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology: From cell to bedside, 3rd edn. Philadelphia: WB Saunders, 2005; 115-126.
9. Cabo C, Boyden PA. Extracellular space attenuates the effect of gap junctional remodeling on wave propagation: A computational study. Biophys J 2009; 96: 3092-3101.
10. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 1993; 88: 864-875.
11. Kostin S, Dammer S, Hein S, Klovekorn WP, Bauer EP, Schaper J. Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res 2004; 62: 426-436.
12. De Groot JR, Coronel R. Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis. Cardiovasc Res 2004; 62: 323-334.
13. Janse MJ. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 2004; 61: 208-217.
14. Kjølbye AL, Dikshteyn M, Eloff BC, Deschênes I, Rosenbaum DS. Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans. Am J Physiol Heart Circ Physiol 2008; 294: 41-49.
15. Sasano C, Honjo H, Takagishi Y, Uzzaman M, Emdad L, Shimizu A, et al. Internalization and dephosphorylation of connexin43 in hypertrophied right ventricles of rats with pulmonary hypertension. Circ J 2007; 71: 382-389.
16. Salameh A, Frenzel C, Boldt A, Rassler B, Glawe I, Schulte J, et al. Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression. FASEB J 2006; 20: 365-367.
17. Salameh A, Krautblatter S, Baessler S, Karl S, Rojas Gomez D, Dhein S, et al. Signal transduction and transcriptional control of cardiac connexin43 up-regulation after alpha 1-adrenoceptor stimulation. J Pharmacol Exp Ther 2008; 326: 315-322.
18. Shyu KG, Wang BW, Yang YH, Tsai SC, Lin S, Lee CC. Amphetamine activates connexin43 gene expression in cultured neonatal rat cardiomyocytes through JNK and AP-1 pathway. Cardiovasc Res 2004; 63: 98-108.
19. Zeevi-Levin N, Barac YD, Reisner Y, Reiter I, Yaniv G, Meiry G, et al. Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res 2005; 66: 64-73.
20. Inoue N, Ohkusa T, Nao T, Lee JK, Matsumoto T, Hisamatsu Y, et al. Rapid electrical stimulation of contraction modulates gap junction protein in neonatal rat cultured cardiomyocytes: Involvement of mitogen-activated protein kinases and effects of angiotensin IIreceptor blocker. J Am Coll Cardiol 2004; 44: 914-922.
21. Shanker AJ, Yamada K, Green KG, Yamada KA, Saffitz JE. Matrixprotein- specific regulation of Cx43 expression in cardiac myocytes subjected to mechanical load. Circ Res 2005; 96: 558-566.
22. Suzuki S, Ohkusa T, Sato T, Yoshida M, Yasui K, Miwa K, et al. Effects of aldosterone on Cx43 gap junction expression in neonatal rat cultured cardiomyocytes. Circ J 2009; 73: 1504-1512.
23. Martin PE, Evans WH. Incorporation of connexins into plasma membranes and gap junctions. Cardiovasc Res 2004; 62: 378-387.
24. Paulson AF, Lampe PD, Meyer RA, TenBroek E, Atkinson MM, Walseth TF, et al. Cyclic AMP and LDL trigger a rapid enhancement in gap junction assembly through a stimulation of connexin trafficking. J Cell Sci 2000; 113: 3037-3049.
25. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res 2005; 97: 655-662.
26. Matsuda T, Fujio Y, Nariai T, Ito T, Yamane M, Takatani T, et al. N-cadherin signals through Rac1 determine the localization of connexin 43 in cardiac myocytes. J Mol Cell Cardiol 2006; 40: 495-502.
27. Ek-Vitorin JF, King TJ, Heyman NS, Lampe PD, Burt JM. Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation. Circ Res 2006; 98: 1498-1505.
28. Ueyama T, Yoshida K, Senba E. Emotional stress induces immediate- early gene expression in rat heart via activation of alpha- and beta-adrenoceptors. Am J Physiol 1999; 277: H1553-H1561.
29. Ueyama T, Aki T, Senba E, Hatanaka K, Yoshida K. Emotional stress activates MAP kinase in the rat heart. Life Sci 2001; 69: 1927-1934.
30. Unuma K, Shintani-Ishida K, Tsushima K, Shimosawa T, Ueyama T, Kuwahara M, et al. Connexin-43 redistribution and gap junction activation during forced restraint protects against sudden arrhythmic death in rats. Circ J 2010; 74: 1087-1095.
31. Shintani-Ishida K, Unuma K, Yoshida K. Ischemia enhances translocation of connexin43 and gap junction intercellular communication, thereby propagating contraction band necrosis after reperfusion. Circ J 2009; 73: 1661-1668.
32. Kuwahara M, Yayou K, Ishii K, Hashimoto S, Tsubone H, Sugano S. Power spectral analysis of heart rate variability as a new method for assessing autonomic activity in the rat. J Electrocardiol 1994; 27: 333-337.
33. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, et al. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988; 22: 447-455.
34. Yoshida K, Hirata T, Akita Y, Mizukami Y, Yamaguchi K, Sorimachi Y, et al. Translocation of protein kinase C-alpha, delta and epsilon isoforms in ischemic rat heart. Biochim Biophys Acta 1996; 1317: 36-44.
35. Kawata H, Yoshida K, Kawamoto A, Kurioka H, Takase E, Sasaki Y, et al. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res 2001; 88: 696-704.
36. Sakuma I, Togashi H, Yoshioka M, Saito H, Yanagida M, Tamura M, et al. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: A role for nitric oxide in the central regulation of sympathetic tone? Circ Res 1992; 70: 607-611.
37. Loor G, Schumacker PT. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ 2008; 15: 686-690.
38. Stanbouly S, Kirshenbaum LA, Jones DL, Karmazyn M. Sodium hydrogen exchange 1 (NHE-1) regulates connexin 43 expression in cardiomyocytes via reverse mode sodium calcium exchange and c-Jun NH2-terminal kinase-dependent pathways. J Pharmacol Exp Ther 2008; 327: 105-113.
39. Yoshida K, Aki T, Harada K, Shama KM, Kamoda Y, Suzuki A, et al. Translocation of HSP27 and MKBP in ischemic heart. Cell Struct Funct 1999; 24: 181-185.
40. Gutterman DD, Morgan DA, Miller FJ. Effect of brief myocardial ischemia on sympathetic coronary vasoconstriction. Circ Res 1992; 7: 960-969.
41. Sipido KR. CaM or cAMP: Linking beta-adrenergic stimulation to 'leaky' RyRs. Circ Res 2007; 100: 296-298.
42. Desantiago J, Ai X, Islam M, Acuna G, Ziolo MT, Bers DM, et al. Arrhythmogenic effects of ß-adrenergic stimulation in the failing heart are attributable to enhanced SR Ca2+ load. Circ Res 2008; 102: 1389-1397.
43. Janse MJ. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 2004; 61: 208-217.
44. Singh BN. Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: An overview. J Cardiovasc Pharmacol Ther 2005; 10: 3-14.